AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0169
+0.0029 (20.71%)
At close: Jan 23, 2026
AXIM Biotechnologies Employees
As of June 30, 2024, AXIM Biotechnologies had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the same quarter last year.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
$13,271
Profits / Employee
-$590,839
Market Cap
6.01M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Carisma Therapeutics | 46 |
| Clearside Biomedical | 32 |
| Vaccinex | 27 |
| Mosaic ImmunoEngineering | 8 |
| Galera Therapeutics | 3 |
AXIM Biotechnologies News
- 1 year ago - VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease - Business Wire
- 2 years ago - AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test - Business Wire
- 2 years ago - Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 2 years ago - AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch - GlobeNewsWire